🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsRybelsus on an empty stomach is ruining my mornings — anyone have experience? Page 2

Rybelsus on an empty stomach is ruining my mornings — anyone have experience?

PharmacoVig_BOS Fri, Apr 26, 2024 at 1:04 PM 41 replies 2,693 viewsPage 2 of 9
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Apr 26, 2024 at 3:54 PM#6

Wait there's going to be a 50mg oral version?? That would be a game changer honestly. I would switch in a heartbeat if the efficacy matched injectable.

45 4Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 42 others
Reply Quote Save Share Report
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Apr 26, 2024 at 4:11 PM#7

For the travel issue specifically — a few tips that helped me keep using injectable while traveling constantly:

  • FRIO insulin cooling wallets — no refrigeration needed, just soak in water. Keeps pens cool for 48-72 hours.
  • TSA has NEVER given me an actual problem with my Wegovy pens. I keep them in a clear bag with the prescription label visible. Just tell them it's medication.
  • Most hotels will put medication in their kitchen fridge if you ask the front desk.
  • Wegovy pens are actually stable at room temperature (up to 86°F/30°C) for up to 28 days, so for short trips you might not even need refrigeration.
37 10FitDadDave, RunnerRach, TrialNerd_Beth and 34 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Apr 26, 2024 at 4:28 PM#8

Ok this is all super helpful. It sounds like switching to oral at my current dose (1.7mg injectable) would be a downgrade in efficacy, and the daily fasting requirement might actually be MORE of a hassle than weekly injections.

I think I'll stick with injectable and try the FRIO wallet for travel. And keep my eye out for when/if the higher-dose oral formulation gets approved.

Thanks everyone — saved me from making a mistake! 🙏

9 17lori_vegas, Dr.PulmRoch, maya_sedona and 6 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Apr 26, 2024 at 4:45 PM#9

Smart decision. One more data point: the oral 50mg formulation from OASIS 1 also had higher rates of GI side effects compared to injectable 2.4mg in cross-trial comparisons. The 50mg pill delivers a LOT of semaglutide to the stomach lining even if only 1% is absorbed systemically, and that local GI exposure may cause more nausea/vomiting. Something to factor in if/when it becomes available.

— pharma_data_guy | PharmD | GLP-1 pharmacology nerd
Last edited: Apr 26, 2024 at 7:45 PM
42 10Dr.LeslieOBGYN, MikeNYC_runner and 39 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register